- Conditions
- Post-menopausal Osteoporosis
- Interventions
- Placebo, Zoledronic acid
- Drug
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Eligibility
- 65 Years and older · Female only
- Enrollment
- 190 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2013
- U.S. locations
- 10
- States / cities
- San Diego, California • Lakewood, Colorado • Gainesville, Georgia + 7 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 76
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Osteopenia, Osteoporosis
- Interventions
- risedronate, alendronate
- Drug
- Lead sponsor
- Warner Chilcott
- Industry
- Eligibility
- 40 Years to 75 Years · Female only
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2004
- U.S. locations
- 2
- States / cities
- Gainesville, Florida • New Orleans, Louisiana
- Conditions
- Post Menopausal Osteoporosis
- Interventions
- ibandronate [Bonviva/Boniva]
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 55 Years to 80 Years · Female only
- Enrollment
- 1,395 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2005
- U.S. locations
- 19
- States / cities
- Little Rock, Arkansas • Irvine, California • Rancho Mirage, California + 16 more
- Conditions
- Bone Loss, Osteoporosis, Breast Cancer
- Interventions
- risedronate
- Drug
- Lead sponsor
- Susan L. Greenspan
- Other
- Eligibility
- 55 Years and older · Female only
- Enrollment
- 109 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2013
- U.S. locations
- 1
- States / cities
- Pittsburgh, Pennsylvania
- Conditions
- Osteoporosis
- Interventions
- Romosozumab
- Drug
- Lead sponsor
- Amgen
- Industry
- Eligibility
- 55 Years to 85 Years · Female only
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012
- U.S. locations
- 9
- States / cities
- Tucson, Arizona • Walnut Creek, California • Gainesville, Georgia + 6 more
- Conditions
- Postmenopausal Osteoporosis
- Interventions
- RGB-14-P, Prolia®
- Drug
- Lead sponsor
- Gedeon Richter Plc.
- Industry
- Eligibility
- 60 Years to 90 Years · Female only
- Enrollment
- 473 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 4
- States / cities
- Miami, Florida • Miami Lakes, Florida • Decatur, Georgia + 1 more
- Conditions
- Osteoporosis, Postmenopausal
- Interventions
- risedronate sodium
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 55 Years to 85 Years · Female only
- Enrollment
- 290 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2007
- U.S. locations
- 1
- States / cities
- Bridgewater, New Jersey
- Conditions
- Osteoporosis, Multiple Myeloma
- Interventions
- Romosozumab
- Drug
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 10 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2027
- U.S. locations
- 7
- States / cities
- Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more
- Conditions
- Postmenopausal Osteoporosis
- Interventions
- Ibandronate
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- Female only
- Enrollment
- 1,711 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2006
- U.S. locations
- 142
- States / cities
- Birmingham, Alabama • Columbiana, Alabama • Huntsville, Alabama + 128 more
- Conditions
- Osteoporosis
- Interventions
- Apomine
- Drug
- Lead sponsor
- Genzyme, a Sanofi Company
- Industry
- Eligibility
- 45 Years to 75 Years · Female only
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2004
- U.S. locations
- 2
- States / cities
- Omaha, Nebraska • West Haverstraw, New York
- Conditions
- Postmenopausal Women With Osteoporosis
- Interventions
- Romosozumab, Alendronate, Placebo to Romosozumab, Placebo to Alendronate
- Biological · Drug
- Lead sponsor
- Amgen
- Industry
- Eligibility
- 55 Years to 90 Years · Female only
- Enrollment
- 4,093 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2017
- U.S. locations
- 32
- States / cities
- Birmingham, Alabama • Peoria, Arizona • Phoenix, Arizona + 29 more
- Conditions
- Postmenopausal Osteoporosis
- Interventions
- Denosumab (CP2), Denosumab (CP4)
- Drug
- Lead sponsor
- Amgen
- Industry
- Eligibility
- 55 Years to 100 Years · Female only
- Enrollment
- 394 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 10
- States / cities
- Santa Maria, California • South Lake Tahoe, California • Lakewood, Colorado + 7 more
- Conditions
- Postmenopausal, Osteopenia, Rheumatoid Arthritis, Osteoporosis
- Interventions
- Etanercept, Denosumab
- Drug
- Lead sponsor
- Amgen
- Industry
- Eligibility
- 45 Years to 80 Years · Female only
- Enrollment
- 19 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2016
- U.S. locations
- 2
- States / cities
- Duncansville, Pennsylvania • Dallas, Texas
- Conditions
- Post Menopausal Osteoporosis
- Interventions
- Risedronate, ibandronate [Bonviva/Boniva]
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 55 Years to 80 Years · Female only
- Enrollment
- 356 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 48
- States / cities
- Birmingham, Alabama • Mesa, Arizona • Scottsdale, Arizona + 42 more
- Conditions
- Osteoporosis
- Interventions
- Teriparatide, Risedronate, Placebo, Calcium, Vitamin D
- Drug · Dietary Supplement
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 224 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2015
- U.S. locations
- 6
- States / cities
- Fort Lauderdale, Florida • New Port Richey, Florida • Orlando, Florida + 3 more
- Conditions
- Osteoporosis, Postmenopausal, Back Pain, Spinal Fracture
- Interventions
- teriparatide, risedronate, placebo
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 45 Years and older · Female only
- Enrollment
- 712 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2010
- U.S. locations
- 20
- States / cities
- Birmingham, Alabama • Montgomery, Alabama • Peoria, Arizona + 17 more
- Conditions
- Osteoporosis, Postmenopausal Osteoporosis
- Interventions
- Placebo, BA058 80 mcg, teriparatide
- Drug
- Lead sponsor
- Radius Health, Inc.
- Industry
- Eligibility
- 50 Years to 85 Years · Female only
- Enrollment
- 2,463 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2014
- U.S. locations
- 5
- States / cities
- Lakewood, Colorado • Miami, Florida • North Miami, Florida + 2 more
- Conditions
- Post Menopausal Osteoporosis
- Interventions
- Abaloparatide Transdermal (50 mcg), Abaloparatide Transdermal (100 mcg), Abaloparatide Transdermal (150 mcg), Abaloparatide Injection (80 mcg), Abaloparatide Placebo
- Drug
- Lead sponsor
- Radius Health, Inc.
- Industry
- Eligibility
- Up to 85 Years · Female only
- Enrollment
- 250 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 3
- States / cities
- Lakewood, Colorado • Atlanta, Georgia • Bethesda, Maryland
- Conditions
- Postmenopausal Osteoporosis
- Interventions
- AGA2118, Placebo
- Drug · Other
- Lead sponsor
- Angitia Biopharmaceuticals
- Industry
- Eligibility
- 55 Years to 80 Years · Female only
- Enrollment
- 379 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 5
- States / cities
- Birmingham, Alabama • Gainesville, Georgia • Albuquerque, New Mexico + 2 more
- Conditions
- Post Menopausal Osteoporosis
- Interventions
- Ibandronate [Bonviva/Boniva], Calcium, Vitamin D
- Drug · Dietary Supplement
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 55 Years to 80 Years · Female only
- Enrollment
- 1,609 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2004
- U.S. locations
- 20
- States / cities
- Irvine, California • Loma Linda, California • Los Angeles, California + 17 more
- Conditions
- Postmenopausal Osteoporosis
- Interventions
- abaloparatide, abaloparatide solid microstructured transdermal system
- Combination Product
- Lead sponsor
- Radius Health, Inc.
- Industry
- Eligibility
- 50 Years to 85 Years · Female only
- Enrollment
- 511 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 77
- States / cities
- Birmingham, Alabama • Anchorage, Alaska • Glendale, Arizona + 65 more
- Conditions
- Post Menopausal Osteoporosis
- Interventions
- Ibandronate
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- Female only
- Enrollment
- 308 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2006
- U.S. locations
- 50
- States / cities
- Montgomery, Alabama • Chandler, Arizona • Peoria, Arizona + 46 more
- Conditions
- Osteoporosis
- Interventions
- placebo, ALX1-11
- Drug
- Lead sponsor
- Shire
- Industry
- Eligibility
- 45 Years and older · Female only
- Enrollment
- 2,532 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2000 – 2003
- U.S. locations
- 107
- States / cities
- Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 95 more
- Conditions
- Osteoporosis Postmenopausal
- Interventions
- Risedronate (HMR4003)
- Drug
- Lead sponsor
- Sanofi
- Industry
- Eligibility
- 50 Years and older · Female only
- Enrollment
- 1,231 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2007
- U.S. locations
- 1
- States / cities
- Bridgewater, New Jersey